What is the recommended dose of cefalexin (cephalexin) for infants with uncomplicated infections, considering their weight and potential impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefalexin Dosing for Infants

For infants, cefalexin is dosed at 25-50 mg/kg/day divided into 2-4 doses depending on infection severity, with the FDA-approved standard being 25-50 mg/kg/day in divided doses for most infections. 1

Standard Dosing by Age and Indication

Infants 29-60 Days Old

  • For urinary tract infections: 50-100 mg/kg/day divided into 4 doses (every 6 hours) 2, 3
  • This dosing is recommended when transitioning from parenteral therapy in well-appearing febrile infants 2

General Pediatric Dosing (>1 month)

  • Mild to moderate infections: 25-50 mg/kg/day divided into 2-4 doses 1
  • Severe infections: Up to 100 mg/kg/day in divided doses 1
  • Otitis media: 75-100 mg/kg/day in 4 divided doses 1

Infection-Specific Recommendations

Methicillin-Susceptible Staphylococcus aureus (MSSA)

  • 75-100 mg/kg/day divided into 3-4 doses for MSSA skin and soft tissue infections or bone/joint infections 3, 4
  • Recent evidence supports 45 mg/kg/dose (maximum 1.5 g) three times daily as an effective alternative with improved adherence 4

Streptococcal Pharyngitis and Skin Infections

  • Total daily dose may be divided and administered every 12 hours in patients over 1 year of age 1
  • Treatment duration should be at least 10 days for β-hemolytic streptococcal infections 1

Critical Considerations for Renal Impairment

Dosage adjustment is essential in infants with impaired renal function, as cefalexin is primarily renally eliminated 1. The FDA label does not provide specific pediatric renal dosing adjustments, but close monitoring and dose reduction based on creatinine clearance is necessary 1.

Important Limitations

  • Cefalexin is NOT appropriate for:
    • Pneumococcal pneumonia (use amoxicillin 90 mg/kg/day instead) 3
    • β-lactamase-producing organisms 3
    • Methicillin-resistant Staphylococcus aureus (MRSA) 3
    • Serious infections requiring broader coverage (consider amoxicillin-clavulanate or cefazolin) 3

Practical Administration

  • Suspension preparation: Available as 125 mg/5 mL or 250 mg/5 mL suspensions 1
  • Storage: After mixing, refrigerate and use within 14 days 1
  • Dosing frequency: Four times daily dosing is standard, though twice or three times daily regimens show promise for improving adherence in older children 4, 5

Emerging Evidence for Young Infants

Recent pharmacokinetic modeling in infants 7-60 days old suggests 25 mg/kg/dose every 6-8 hours achieves appropriate pharmacodynamic targets for Enterobacterales and MSSA 6. For Enterobacterales, every 6 hours dosing is preferred; for MSSA, every 8 hours may be sufficient 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cefalexin Dosing for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended dose of cephalexin for an infant weighing 24 kilograms?
What is the recommended dose of cefalexin (cephalexin) for pediatric patients with varying weights and potential impaired renal function?
What is the recommended dosage of cefalexin (cephalexin) for a 3-month-old infant?
What is the recommended dosage of cefalexin (a cephalosporin antibiotic) for pediatric patients with varying weights and potential impaired renal function?
What is the recommended dosage of cefalexin (cephalexin) for a 2-month-old infant?
What medication should be added to the treatment regimen of a patient with heart failure and reduced ejection fraction (EF) and dilated cardiomyopathy, who is already on Valsartan (Angiotensin II receptor antagonist), statin (HMG-CoA reductase inhibitor), metoprolol (beta-blocker), spironolactone (aldosterone antagonist), and furosemide (loop diuretic)?
Should a woman with polycystic ovary syndrome (PCOS) and metabolic risks, including hypertriglyceridemia and hypercholesterolemia, who is taking letrozole and metformin, discontinue metformin at the time of a positive pregnancy test or at the end of the first trimester?
What is the recommended treatment for a patient with a rectal grade 1 neuroendocrine tumour?
What is the recommended antibiotic regimen for a nondiabetic patient with wet gangrene of the foot?
What can be used to relieve sulfuric gases and bloating in a patient taking GLP-1 (Glucagon-like peptide-1) receptor agonists?
What makes severe asthma life-threatening in a patient with a peak flow of 30, who has received Salbutamol (albuterol) nebulization up to 5mg without improvement and has a respiratory rate (RR) greater than 28?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.